Efficacy and effectiveness of omalizumab in the treatment of childhood asthma

Expert Review of Respiratory Medicine
Miguel Tortajada-GirbésLydia Zapatero

Abstract

Omalizumab is a monoclonal antibody that binds and inhibits free serum immunoglobulin E, a mediator involved in the clinical manifestations of allergic asthma. Evidence for its efficacy and safety in the treatment of moderate-to-severe allergic asthma is based primarily on studies in adolescents and adults. However, there is increasing evidence of its utility in children with allergic asthma aged 6-12 years. Areas covered: This article reviews efficacy, safety, and effectiveness of omalizumab in the treatment of moderate-to-severe allergic asthma in children aged 6-12 years in clinical trials and in studies in clinical practice. Pharmacoeconomic aspects of its use among this population and the positioning of omalizumab in pediatric asthma management guidelines are also discussed. Additionally, an algorithm for the management of poorly controlled severe pediatric asthma in children older than 6 years is proposed. Electronic databases, such as PubMed, were searched for terms Asthma and Omalizumab and for asthma management guidelines. Expert commentary: Add-on omalizumab is an effective maintenance therapy in children aged 6-12 years with poorly controlled moderate-to-severe allergic asthma treated with medium-high inhaled cortico...Continue Reading

References

Feb 8, 2005·Arthritis and Rheumatism·Andreas Maetzel
Oct 28, 2006·PharmacoEconomics·Stephen Birch, Amiram Gafni
Feb 25, 2009·Thorax·C K W LaiUNKNOWN International Study of Asthma and Allergies in Childhood Phase Three Study Group
Mar 17, 2009·Archivos de bronconeumología·María Sánchez-BahílloManuel Sánchez-Solís
Oct 30, 2009·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·M Navarro MerinoUNKNOWN Grupo de Trabajo Asma Infantil de la Sociedad Española de Neumología Pediátrica
Nov 17, 2009·The Journal of Allergy and Clinical Immunology·Bob LanierCarlos Fernandez Vidaurre
Dec 4, 2009·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·P M MatricardiS Lau
Apr 10, 2010·Current Medical Research and Opinion·M KulusM Blogg
Dec 28, 2010·Inflammation & Allergy Drug Targets·Monica Di DomenicoAnna Capasso
Mar 18, 2011·The New England Journal of Medicine·William W BusseChristine A Sorkness
Jul 9, 2011·The European Respiratory Journal·A BushUNKNOWN PSACI (Problematic Severe Asthma in Childhood Initiative) group
Dec 31, 2011·The Journal of Allergy and Clinical Immunology·Salvatore TripodiPaolo Maria Matricardi
Apr 27, 2012·Canadian Respiratory Journal : Journal of the Canadian Thoracic Society·M Diane LougheedUNKNOWN Canadian Thoracic Society Asthma Clinical Assembly
Jun 12, 2012·Archives of Disease in Childhood·Malcolm BrodlieDavid A Spencer
Jun 19, 2012·Allergy·N G PapadopoulosR S Zeiger
Aug 28, 2012·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Caroline RizkWilliam H Yang
Oct 3, 2012·Allergy and Asthma Proceedings·Bradley E ChippsSheldon Spector
Dec 12, 2012·Journal of Medical Economics·Floortje van NootenRuth E Brown
Dec 12, 2012·Thorax·Andy Bush, Ian D Pavord
Mar 23, 2013·The European Respiratory Journal·Antoine DeschildreJocelyne Just
Jun 12, 2013·Paediatric Drugs·Paul D Robinson, Peter Van Asperen
Sep 18, 2013·Lancet·Fernando D Martinez, Donata Vercelli
Dec 18, 2013·The European Respiratory Journal·Kian Fan ChungW Gerald Teague
Feb 26, 2014·The Journal of Allergy and Clinical Immunology. in Practice·Christine A SorknessStanley J Szefler
Jul 6, 2014·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Alberto Nahon LevyMaría Victoria Hidalgo Sanjuan
Sep 3, 2014·Allergology International : Official Journal of the Japanese Society of Allergology·Yuhei HamasakiUNKNOWN Japanese Society of Pediatric Allergy and Clinical Immunology
Nov 19, 2014·Paediatric Drugs·Amelia LicariGian Luigi Marseglia
May 13, 2015·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Gustavo J Rodrigo, Hugo Neffen
May 17, 2015·Expert Opinion on Drug Discovery·Amelia LicariGiorgio Ciprandi
May 30, 2015·The European Respiratory Journal·Antoine DeschildreJocelyne Just
Nov 1, 2015·The Journal of Allergy and Clinical Immunology·Stephen J TeachStanley J Szefler
Nov 1, 2014·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·E BergrathS Cope
Aug 11, 2016·Allergology International : Official Journal of the Japanese Society of Allergology·Hiroshi OdajimaSankei Nishima
Oct 18, 2016·Expert Opinion on Drug Metabolism & Toxicology·Maxime LuuFrançoise Goirand
Jan 18, 2017·Journal of Immunology Research·Arnau Navinés-FerrerMargarita Martín
Jan 1, 2014·Allergology International : Official Journal of the Japanese Society of Allergology·Yuhei HamasakiAkihiro Morikawa
Oct 7, 2017·Frontiers in Medicine·Jeffrey Stokes
Dec 8, 2017·Current Respiratory Medicine Reviews·Amelia LicariUNKNOWN Omalizumab in Childhood Asthma Italian Study Group

❮ Previous
Next ❯

Citations

Feb 6, 2019·Current Opinion in Allergy and Clinical Immunology·Louise Selby, Sejal Saglani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergies & Environmental Factors

Environmental factors are strongly associated with the prevalence of allergies and are an increasing health concern worldwide. Discover the latest research on Allergies and Environmental Factors here.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.